Recent research compared treatments for locally advanced cervical cancer and the effect of different lymph node (tiny, bean-shaped organs that help fight infection) removal techniques for early-stage cervical cancer. Another study looked at when to start treatment for ovarian cancer recurrence. In addition, a national survey provided information about discussing fertility preservation.
A new study from Finland shows that a vaccine (Gardasil) developed to prevent cervical cancer could also prevent cancers of the vagina and vulva associated with the human papillomavirus (HPV), the same virus linked to cervical cancer. According to Jorma Paavonen, MD, Professor and Chief Physician, Department of Obstetrics and Gynecology, University of Helsinki, and the study's lead author, HPV is present in 80% of the 6,000 cases of vaginal and vulvar cancers diagnosed in the United States each year.